Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Pfizer Inc PFE

Alternate Symbol(s): N.PFE

Healthcare

Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more

Add To Watchlist

Recent & Breaking News (NYSE:PFE)

Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier Global Consumer Healthcare Company

Business Wire December 19, 2018

Pfizer Invites Public to View and Listen to Webcast of January 29 Conference Call with Analysts

Business Wire December 18, 2018

Kineta Enters Research Collaboration and License Agreement with Pfizer to Develop New Cancer Immunotherapies

PR Newswire December 17, 2018

Pfizer Declares First-Quarter 2019 Dividend

Business Wire December 14, 2018

Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, ZIRABEV™ (bevacizumab)

Business Wire December 14, 2018

Pfizer Initiates Phase 3 Program for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older

Business Wire December 14, 2018

Report: Developing Opportunities within Pfizer, Bed Bath & Beyond, Vishay Intertechnology, Cloudera, Markel, and QTS Realty Trust — Future Expectations, Projections Moving into 2018

GlobeNewswire December 12, 2018

Thinking about buying stock in Caterpillar Inc., DSW Inc., Innovate Bio, Oncosec Medical or Pfizer Inc.?

PR Newswire December 11, 2018

A Peek Into The Markets: US Stock Futures Surge Ahead Of Producer Price Index

Benzinga.com December 11, 2018

Biotechnologies are Improving as the Global Oncology Market Grows

PR Newswire December 3, 2018

Option-trading strategies for Advanced Micro Devices, Cisco Systems, Dicks Sporting Goods, Intel, and Pfizer Inc.

PR Newswire December 3, 2018

Pfizer Presents Positive 26-Week Data For PF-05280586, A Potential Biosimilar To Rituximab, At The American Society Of Hematology Annual Meeting

Business Wire December 2, 2018

Pfizer Reaches a Global Agreement with AbbVie

Business Wire November 30, 2018

The Daily Biotech Pulse: EC Nod For Shire, Mirati Gets FDA Clearance For Cancer Drug Trials, PhaseBio's First Earnings

Benzinga.com November 30, 2018

The Global Cancer Therapy Market is set to Grow on the Wide use of Chemotherapy

PR Newswire November 28, 2018

Pfizer Receives Six Months Pediatric Exclusivity for LYRICA® (pregabalin)

Business Wire November 27, 2018

U.S. FDA Approves DAURISMO™ (glasdegib) for Adult Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML) for Whom Intensive Chemotherapy is Not an Option

Business Wire November 21, 2018

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Business Wire November 21, 2018

Here's What's At Stake For Your Investments In The 2018 Midterms

Benzinga.com November 6, 2018

New Clinical Oncology Collaboration Between Nektar and Pfizer to Evaluate Combination of NKTR-214, a CD122-Biased Agonist, with Avelumab and Talazoparib or Enzalutamide in Multiple Cancers

PR Newswire November 6, 2018